Does endoscopic duodenal-jejunal bypass liner rapidly improve type 2 diabetes?
The data indicate DJBL to be a promising treatment for obesity and type 2 diabetes, causing rapid improvement of glycemic control paralleled by changes in gut hormones.
Exposure to HCVcc modulates the pattern of cytokines produced by NK cells, leading to reduced antiviral activity.